Heart Blocks Treatment Devices Global Market Size, Top Companies, Share, Growth And Forecast 2033 | GE HealthCare, Abbott Laboratories, Medtronic PLC, Stryker Corporation, LivaNova PLC

The heart blocks treatment devices market size has grown strongly in recent years. It will grow from $3.11 billion in 2023 to $3.3 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to growth in implantable cardioverter defibrillators (icds), evolution of cardiac resynchronization therapy (crt), miniaturization and leadless devices, clinical trials and evidence-based medicine, guidelines and recommendations, increasing incidence of cardiovascular diseases.

The heart blocks treatment devices market size is expected to see strong growth in the next few years. It will grow to $4.13 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to wireless connectivity and remote monitoring, expansion of wearable cardioverter defibrillators (wcds), personalized treatment algorithms, patient-centric design and comfort, increased adoption of mri-compatible device.. Major trends in the forecast period include growing integration of telemedicine platforms, remote programming and updates, ai-driven predictive maintenance, emphasis on user experience, expansion of home-based care..

Market Overview -
Heart blocks treatment devices are medical devices used to manage and correct disruptions in the electrical conduction system of the heart, specifically heart block. These devices help regulate the heart's rhythm and ensure proper coordination between the heart's chambers (atria and ventricles).

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12062&type=smp

Cardiovascular Disease Surge Propels Expansion Of Heart Block Treatment Devices Market
The rising prevalence of cardiovascular disease is expected to propel the growth of the heart blocks treatment devices market going forward. Cardiovascular diseases affect the heart and blood vessels and include conditions such as coronary artery disease, heart failure, and stroke. The rapidly increasing incidence of cardiovascular disease is mostly driven by the aging population, changes in lifestyle and diet, and increasing rates of obesity and diabetes, where heart blocks treatment devices can be used to treat cardiovascular disorders by addressing abnormalities or defects in the structures and blocks of the heart. For instance, in May 2023, according to an article by the Centers for Disease Control and Prevention, a US-based national public health agency, one person dies every 33 seconds in the United States from cardiovascular disease. About 695,000 people in the United States died from heart disease in 2021; that's 1 in every 5 deaths. Therefore, the rising prevalence of cardiovascular disease is driving the growth of the heart blocks treatment devices market.

Competitive Landscape -
Major companies operating in the heart blocks treatment devices market report are MicroPort Scientific Corporation, GE HealthCare, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, Nihon Kohden Corporation, Lepu Medical Technology (Beijing) Co., Zoll Medical Corporation, LivaNova PLC, Abiomed Inc., Cardiac Dimensions, EBR Systems Inc., Endotronix Inc., Calon Cardio, CVRx Inc., BioVentrix Inc., CorWave SA, Leviticus Cardio, BiVACOR, Biotronik SE and CO KG, CorMatrix Cardiovascular, Shree Pacetronix Ltd., Jarvik Heart Inc., Osypka Medical GmbH.

Transforming Heart Blocks Treatment With Minimally Invasive Technology
Technological advancements are a key trend gaining popularity in the heart blocks treatment devices market. Companies operating in the heart blocks treatment devices market are adopting new technologies to sustain their position in the market. For instance, in January 2023, Medtronic, a US-based company engaged in services, medical technology, and solutions launched the world's smallest pacemaker to treat heart block. Micra AV is a miniature, fully self-contained pacemaker that uses a minimally invasive method to provide patients with an atrioventricular (AV) block with innovative pacing technology. This pacemaker is the first to be able to detect atrial activity without the use of a lead or other accessory in the upper chamber of the heart.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/heart-blocks-treatment-devices-global-market-report

Key Segments -
The heart blocks treatment devices market covered in this report is segmented -
1) By Type: First-Degree Heart Block, Second-Degree Heart Block, Third-Degree Heart Block
2) By Product: Transcutaneous Pacing (TCP), Pacemaker, Mediation, Follow-Up Electrophysiology Study
3) By End-user: Hospital Testing, Home treatment, Clinics, Other End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.